Name: Vanda Pharmaceuticals Inc. (VNDA) Balance Sheet
Creator: FinSpry

Vanda Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Vanda Pharmaceuticals Inc. (VNDA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	84.85	102.32	388.26	135.03	52.07	367.74	312.13	257.36
Short-Term Investments	179.00	272.33	252.44	331.83	380.74	306.71	0.00	0.00
Cash & Short-Term Investments	263.85	374.64	388.26	466.86	432.81	367.74	312.13	257.36
Accounts Receivable	54.58	47.10	34.16	33.51	32.47	30.04	26.37	28.78
Inventory	1.85	1.73	1.36	1.19	1.03	1.28	1.14	0.99
Other Current Assets	26.99	15.42	18.31	17.73	12.00	11.23	9.74	0.00
Total Current Assets	347.26	438.89	432.95	519.29	478.30	409.15	354.14	299.13
Non-Current Assets
Property, Plant & Equipment (Net)	13.51	12.68	9.14	10.97	12.39	14.60	15.04	4.42
Intangible Assets	117.09	114.10	121.37	18.57	20.08	21.56	0.00	0.00
Other Non-Current Assets	11.08	9.10	9.99	11.38	8.15	5.09	0.00	4.04
Total Non-Current Assets	141.69	217.31	215.49	114.96	115.49	124.31	129.61	33.00
Total Assets	488.95	656.20	648.44	634.25	593.79	533.46	483.75	332.13
Current Liabilities
Accounts Payable	0.00	3.50	38.46	12.69	0.93	31.51	27.59	15.22
Short-Term Debt	0.00	8.54	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	0.00	31.32	28.92	18.72	31.20	27.99	0.00	0.00
Other Current Liabilities	145.16	87.94	6.41	45.89	39.98	34.43	31.92	0.20
Total Current Liabilities	145.16	99.98	87.70	91.44	74.42	65.94	59.51	53.02
Non-Current Liabilities
Long-Term Debt	7.07	8.09	7.01	8.81	10.06	11.50	12.46	0.00
Other Non-Current Liabilities	9.53	9.59	58.06	6.80	4.39	2.76	0.84	3.69
Total Non-Current Liabilities	16.60	17.68	65.07	15.61	14.45	14.25	13.30	3.69
Total Liabilities	161.76	117.66	103.53	107.05	88.86	80.19	72.80	56.71
Stockholders' Equity
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06	0.00	0.00
Retained Earnings	-394.77	-174.29	-155.42	-157.90	-164.18	-197.09	-220.67	-336.22
Accumulated Other Comprehensive Income	0.63	0.07	-0.03	-1.19	-0.18	0.24	0.25	0.00
Additional Paid-in Capital	721.26	712.71	700.27	686.24	669.22	650.30	631.31	611.59
Shares Outstanding	0.00	58.31	57.53	56.78	55.90	0.00	0.00	0.00
Total Stockholders' Equity	327.19	538.55	544.91	527.20	504.93	453.27	410.95	275.42
Total Liabilities & Equity	488.95	656.20	648.44	634.25	593.79	533.46	483.75	332.13